These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
11. Serum aluminium level in the veneto chronic haemodialysis population: cross-sectional study on 1,026 patients. Piccoli A, Andriani M, Mattiello G, Nordio M, Modena F, Dalla Rosa C. Nephron; 1989 Feb; 51(4):482-90. PubMed ID: 2787000 [Abstract] [Full Text] [Related]
12. The dialysis encephalopathy syndrome. Possible aluminum intoxication. Alfrey AC, LeGendre GR, Kaehny WD. N Engl J Med; 1976 Jan 22; 294(4):184-8. PubMed ID: 1244532 [Abstract] [Full Text] [Related]
13. [The treatment of osteodystrophy in dialyzed uremic patients: results of the first Sardinian audit]. Mereu MC, Bolasco PG, Pinna A, Carzedda LG, Branca GF, Di Lauro L, Cogoni G, Solinas R, Mureddu S. G Ital Nefrol; 2004 Jan 22; 21(4):362-70. PubMed ID: 15470662 [Abstract] [Full Text] [Related]
14. Metabolic bone disease and aluminium contamination in 38 uremic patients. A bone histomorphometric study. Pødenphant J, Heaf JG, Joffe P. Acta Pathol Microbiol Immunol Scand A; 1986 Jan 22; 94(1):1-6. PubMed ID: 3962676 [Abstract] [Full Text] [Related]
15. [Blood aluminum levels in workers in the aluminum industry]. Schlatter C, Steinegger A, Rickenbacher U, Hans C, Lengeyl A. Soz Praventivmed; 1986 Jan 22; 31(2):125-9. PubMed ID: 3716619 [Abstract] [Full Text] [Related]
17. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)]. Boukari M, Rottembourg J, Jaudon MC, Clavel JP, Legrain M, Galli A. Nouv Presse Med; 1978 Jan 14; 7(2):85-8. PubMed ID: 349501 [Abstract] [Full Text] [Related]
18. Middle molecular weight substances in the cerebrospinal fluid of uremic patients. Sperschneider H, Spustova V, Stein G, Dzurik R. Clin Nephrol; 1982 Jun 14; 17(6):298-302. PubMed ID: 7105504 [Abstract] [Full Text] [Related]